Gaucher's disease is:
A child with intellectual disability presenting with hoarseness, frequent dermatitis, and skeletal deformities was diagnosed to have Farber's disease. Which enzyme is deficient in this child?
Which of the following porphyrias is not inherited as an autosomal dominant disorder?
The PRSS1 gene is located on?
An 8-month-old baby girl had normal growth and development for the first few months, but then progressively deteriorated with deafness, blindness, atrophied muscles, inability to swallow, and seizures. Early on in the diagnosis of the child, it was noticed that a cherry-red macula was present in both eyes. Considering the child in the above case, measurement of which one of the following would enable one to determine whether the mutation was in the hexA or hexB gene?
Enzyme deficiency in Farber disease is:
Which of the following is a genetic disorder that does not primarily affect ion channels?
A 34-year-old, G1P0, presents for genetic counseling at 12 weeks' gestation. The patient has two sisters and a brother; her father has hemophilia. Her siblings are not affected, but she has a nephew who is affected. What is the inheritance pattern of this disorder?
Tay-Sachs disease is due to a deficiency of which enzyme?
Congenital 17-hydroxylase deficiency leads to hypertension due to the accumulation of?
Explanation: ***Autosomal recessive inheritance*** - **Gaucher's disease** is caused by a deficiency of the enzyme **glucocerebrosidase**, leading to the accumulation of glucocerebroside in macrophages. - This genetic disorder requires two copies of the defective gene (one from each parent) to manifest, which is characteristic of **autosomal recessive inheritance**. *Autosomal dominant inheritance* - In **autosomal dominant inheritance**, only one copy of the defective gene is needed for the disease to occur, which is not the case for Gaucher's disease. - Affected individuals usually have at least one affected parent, and there is a 50% chance of passing the condition to offspring. *X-linked recessive inheritance* - **X-linked recessive inheritance** primarily affects males, as the gene is located on the X chromosome. - Females are typically carriers and are less commonly affected, which does not describe the inheritance pattern of Gaucher's disease. *X-linked dominant inheritance* - **X-linked dominant inheritance** means the disease can affect both males and females, but females are typically more mildly affected. - All daughters of an affected father will inherit the condition, which is not consistent with Gaucher's disease.
Explanation: ***Correct Answer: Ceramidase*** - Farber's disease, also known as **Farber lipogranulomatosis** or **acid ceramidase deficiency**, is caused by a deficiency in the enzyme **acid ceramidase** - This enzyme is crucial for the breakdown of **ceramide**, leading to its accumulation in various tissues - Accumulation results in the characteristic symptoms: **hoarseness** (from laryngeal involvement), **dermatitis** (subcutaneous nodules), and **skeletal deformities** (joint contractures) - This is a rare autosomal recessive lysosomal storage disorder *Incorrect: Arylsulfatase A* - Deficiency causes **metachromatic leukodystrophy**, a lysosomal storage disorder affecting the nervous system - Presents with progressive neurological deterioration, peripheral neuropathy, and developmental regression - Does not present with the specific constellation of **hoarseness**, **dermatitis**, and **skeletal deformities** seen in Farber's disease *Incorrect: Beta-Glucosidase* - Deficiency in **beta-glucosidase** (glucocerebrosidase) causes **Gaucher disease** - Characterized by **hepatosplenomegaly**, **anemia**, **thrombocytopenia**, and **bone complications** (bone pain, fractures) - The clinical picture differs from Farber's disease presentation *Incorrect: Sphingomyelinase* - Deficiency causes **Niemann-Pick disease** (Types A and B) - Characterized by **sphingomyelin accumulation**, **hepatosplenomegaly**, and **neurodegenerative symptoms** (Type A) - Symptoms differ from the **hoarseness**, **dermatitis**, and **skeletal deformities** characteristic of Farber's disease
Explanation: ***Congenital Erythropoietic Porphyria*** - This porphyria is inherited in an **autosomal recessive** pattern, meaning two copies of the defective gene (one from each parent) are required for the disease to manifest. - It results from a deficiency in **uroporphyrinogen III synthase (URO-synthase)**, leading to the accumulation of uroporphyrinogen I and coproporphyrinogen I isomers. *Acute Intermittent Porphyria* - This is an **autosomal dominant** disorder caused by a deficiency in **hydroxymethylbilane synthase (HMBS)**, also known as porphyrobilinogen deaminase (PBG deaminase). - It primarily affects the nervous system, leading to acute neurovisceral attacks. *Porphyria Cutanea Tarda* - This is **primarily sporadic (acquired)** in about 80% of cases, often associated with hepatic iron overload, alcohol use, hepatitis C, or estrogen use. - Only about 20% of cases are familial with **autosomal dominant** inheritance pattern. - It is caused by a deficiency in **uroporphyrinogen decarboxylase (UROD)**, leading to photosensitivity due to accumulated porphyrins in the skin. *Hereditary Coproporphyria* - This is an **autosomal dominant** disorder caused by a deficiency in **coproporphyrinogen oxidase (CPOX)**. - It can present with both neurovisceral attacks and photosensitivity, depending on the accumulated porphyrins.
Explanation: ***Chr 7q*** - The **PRSS1 gene**, which encodes for **cationic trypsinogen**, is located on the long arm (**q arm**) of **chromosome 7**. - Mutations in this gene are strongly associated with **hereditary pancreatitis**. *Chr 20q* - This chromosome location is associated with various other genes and diseases, but not typically with the **PRSS1 gene** or **hereditary pancreatitis**. - For example, genes related to **diabetes** and **obesity** are found on chromosome 20. *Chr 17p* - This region is known for containing several important genes, such as **TP53** (a tumor suppressor gene), but it is not the location for **PRSS1**. - Deletions or mutations in **17p** are linked to conditions like **Li-Fraumeni syndrome**. *Chr 1p* - **Chromosome 1**, specifically the short arm (**p arm**), contains a large number of genes and is implicated in many diseases, including certain **cancers**. - However, the **PRSS1 gene** is not found at this chromosomal location.
Explanation: ***Globoside*** - A mutation in the **hexA** gene leads to **Tay-Sachs disease** (deficient **HexA**), characterized by the accumulation of **GM2 ganglioside only**. - A mutation in the **hexB** gene leads to **Sandhoff disease** (deficient **HexB**), which results in the accumulation of **both GM2 ganglioside and globoside**, as **HexB** is crucial for the breakdown of **globosides**. - **Measuring globoside levels would differentiate between these two conditions** - elevated in Sandhoff, normal in Tay-Sachs. *GM1* - **GM1 ganglioside** accumulates in **GM1 gangliosidosis**, caused by a deficiency in **beta-galactosidase**, not hexosaminidase A or B. - Clinical features of **GM1 gangliosidosis** overlap but differ from Tay-Sachs or Sandhoff, and it's not directly affected by **hexA** or **hexB** mutations. *GM2* - **GM2 ganglioside** accumulates in **both Tay-Sachs disease** (due to **HexA** deficiency) and **Sandhoff disease** (due to **HexB** deficiency). - Measuring **GM2** alone would confirm a **hexosaminidase deficiency** but **would not differentiate** between a **hexA** (Tay-Sachs) or **hexB** (Sandhoff) mutation, as it is elevated in both conditions. *Glucocerebroside* - **Glucocerebroside** accumulates in **Gaucher disease**, which is caused by a deficiency in the enzyme **glucocerebrosidase**. - This condition has a distinct clinical presentation and is not related to mutations in the **hexA** or **hexB** genes.
Explanation: ***Ceramidase*** - Farber disease, also known as **Farber lipogranulomatosis** or **Farber's disease**, is an autosomal recessive lysosomal storage disorder caused by a deficiency of the enzyme **acid ceramidase**. - This deficiency leads to the accumulation of **ceramide** in various tissues, causing granulomatous lesions, joint deformities, and neurological symptoms. *Arylsulfatase A* - Deficiency of **arylsulfatase A** is associated with **metachromatic leukodystrophy**, a lysosomal storage disorder affecting the nervous system. - This enzyme is crucial for the breakdown of **sulfatides**, not ceramide. *Sphingomyelinase* - A deficiency in **sphingomyelinase** is the hallmark of **Niemann-Pick disease**, specifically types A and B. - This enzyme is responsible for breaking down **sphingomyelin**, leading to its accumulation in organs like the liver, spleen, and brain. *Hexosaminidase A* - A deficiency in **hexosaminidase A** is the cause of **Tay-Sachs disease**, a severe neurodegenerative disorder. - This enzyme is essential for the metabolism of **GM2 ganglioside**, which accumulates in neurons in affected individuals.
Explanation: ***Cystic fibrosis*** - Primarily caused by mutations in the **CFTR gene**, which encodes a **chloride channel**, but it is not classified as a classic channelopathy. - The disease mainly affects **mucus production** rather than direct dysfunction of ion channels in the traditional sense. [1] *Hypokalemic periodic paralysis* - This condition is directly related to **ion channel dysfunction**, specifically affecting **sodium channels** in muscle cells. - It causes episodic **muscle weakness** and hypokalemia due to improper ion transport. *Liddle's syndrome* - A genetic disorder resulting from mutations affecting **epithelial sodium channels**, leading to **hypertension**. - It exemplifies classic channelopathy by causing dysregulation of sodium reabsorption in the kidneys. *Tay-sach's disease* - A ***gangliosidosis*** caused by a deficiency in the enzyme **Hexosaminidase A**, rather than ion channel dysfunction. - It results in the accumulation of **GM2 gangliosides** leading to neurological degeneration, not affecting ion channels directly. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 120-122.
Explanation: ***X-linked inheritance*** - Hemophilia is an **X-linked recessive disorder** - An affected father passes his X chromosome mutation to **all daughters**, making them **obligate carriers** (not affected but carry the gene) - The affected nephew (son of patient's sister) confirms the patient's sister is a carrier who passed the affected X chromosome to her son - Classic pattern: affected males, carrier females, skips generations through female carriers *Autosomal recessive* - Would require both parents to be carriers for offspring to be affected - An affected father would pass one mutant allele to all children, but this wouldn't make daughters obligate carriers unless mother also carried the gene - Pattern of father → carrier daughter → affected grandson is not typical of autosomal recessive inheritance *Mitochondrial inheritance* - Only transmitted from mother to **all children** regardless of gender - Affected father **cannot** pass mitochondrial disorders to offspring - Would show maternal transmission pattern with all children of affected mothers being affected *Multifactorial inheritance* - Involves combination of multiple genes and environmental factors - Does not follow clear Mendelian pattern - The distinct single-gene pattern (affected father, carrier daughters, affected male grandchild) indicates X-linked recessive, not multifactorial
Explanation: ***Hexosaminidase A*** - **Tay-Sachs disease** is caused by a genetic deficiency in the lysosomal enzyme **hexosaminidase A (HexA)**. - This deficiency leads to the accumulation of **GM2 ganglioside** in neuronal cells, particularly in the brain, causing progressive neurodegeneration. *Hexosaminidase B* - A deficiency in **hexosaminidase B** is associated with **Sandhoff disease**, a lysosomal storage disorder similar to Tay-Sachs but typically more severe. - While HexA is composed of alpha and beta subunits, a deficiency specifically in the beta subunit is characteristic of Sandhoff disease. *α-galactosidase* - A deficiency in **α-galactosidase** is responsible for **Fabry disease**, an X-linked lysosomal storage disorder. - It leads to the accumulation of **globotriaosylceramide (Gb3)**, primarily affecting the kidneys, heart, and nervous system, and does not present with the neurological symptoms of Tay-Sachs. *Sphingomyelinase* - A deficiency in **sphingomyelinase** causes **Niemann-Pick disease (Type A and B)**, another lysosomal storage disorder. - This leads to the accumulation of **sphingomyelin** in various organs, resulting in hepatosplenomegaly, neurodegeneration (in Type A), and lung disease, distinct from Tay-Sachs.
Explanation: ***Deoxycorticosterone*** - **17-hydroxylase deficiency** blocks the conversion of **pregnenolone** to **17-hydroxypregnenolone** and **progesterone** to **17-hydroxyprogesterone**, leading to an accumulation of precursors in the **mineralocorticoid pathway**. - This accumulation results in elevated levels of **deoxycorticosterone (DOC)**, a potent mineralocorticoid, which causes **sodium retention** and **hypertension**. *Cortisol* - **17-hydroxylase deficiency** prevents the synthesis of **cortisol**, as **17-hydroxyprogesterone** is a necessary intermediate. - Therefore, **cortisol levels are low**, not elevated, in this condition. *17-hydroxy pregnenediol* - **17-hydroxylase deficiency** directly impairs the formation of **17-hydroxypregnenolone** from **pregnenolone**. - Consequently, the levels of **17-hydroxypregnenolone** are very low or undetectable, not accumulated, in this disorder. *17-hydroxy progesterone* - The enzyme **17-hydroxylase** is required for the conversion of **progesterone** to **17-hydroxyprogesterone**. - Thus, the deficiency of this enzyme leads to **decreased levels of 17-hydroxyprogesterone**, rather than its accumulation.
Single Gene Disorders
Practice Questions
Biochemical Diagnosis of Genetic Disorders
Practice Questions
Inborn Errors of Metabolism
Practice Questions
Lysosomal Storage Diseases
Practice Questions
Glycogen Storage Diseases
Practice Questions
Disorders of Lipoprotein Metabolism
Practice Questions
Disorders of Purine and Pyrimidine Metabolism
Practice Questions
Hemoglobinopathies
Practice Questions
Porphyrias
Practice Questions
Biochemical Markers for Disease Diagnosis
Practice Questions
Newborn Screening for Genetic Disorders
Practice Questions
Enzyme Replacement Therapy
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free